Express Scripts (NASDAQ: ESRX) reported Q1 EPS of $1.33, $0.01 better than the analyst estimate of $1.32. Revenue for the quarter came in at $24.66 billion versus the consensus estimate of $24.99 billion.

• Adjusted claims of 351.7 million, down 1% – See Table 1
• GAAP net income of $546.3 million, up 4%
• GAAP earnings per diluted share of $0.90, up 11%
• EBITDA of $1,496.2 million, up 3% – See Table 3
• EBITDA per adjusted claim of $4.25, up 4% – See Table 3
• Adjusted net income of $805.4 million, up 2% – See Tables 5 and 5A
• Adjusted earnings per diluted share of $1.33, up 9% - See Table 4
• Net cash flow provided by operating activities of $1,000.4 million, up 33%

GUIDANCE:

Express Scripts sees FY2017 EPS of $6.82-$7.02, versus the consensus of $6.93.

For earnings history and earnings-related data on Express Scripts (ESRX) click here.